Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02661659
What this trial is testing

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
University of Chicago
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129772
What this trial is testing

Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer RecurrentNasopharyngeal Cancinoma (NPC)
The University of Hong Kong 53
Testing effectiveness (Phase 2)Study completedNCT00453154
What this trial is testing

Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaRecurrent Lung Small Cell Carcinoma
National Cancer Institute (NCI) 156
Large-scale testing (Phase 3)Active Not RecruitingNCT04884360
What this trial is testing

D9319C00001- 1L OC Mono Global RCT

Who this might be right for
Ovarian Cancer
AstraZeneca 366
Large-scale testing (Phase 3)UnknownNCT03403829
What this trial is testing

Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 360
Large-scale testing (Phase 3)UnknownNCT02383030
What this trial is testing

Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients

Who this might be right for
Metastatic Breast Cancer
Consorzio Oncotech 156
Testing effectiveness (Phase 2)Study completedNCT02129257
What this trial is testing

Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hellenic Cooperative Oncology Group 73
Testing effectiveness (Phase 2)UnknownNCT02955628
What this trial is testing

RICE-ibrutinib in Relapsed DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Recurrent
Singapore General Hospital 34
Testing effectiveness (Phase 2)UnknownNCT04447612
What this trial is testing

Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
The University of Hong Kong 118
Large-scale testing (Phase 3)Study completedNCT02184195
What this trial is testing

Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Who this might be right for
Germline BRCA1/2 Mutations andMetastatic Adenocarcinoma of the Pancreas
AstraZeneca 154
Testing effectiveness (Phase 2)UnknownNCT04319471
What this trial is testing

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 70
Large-scale testing (Phase 3)Study completedNCT01144364
What this trial is testing

MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 234
Not applicableStudy completedNCT03261674
What this trial is testing

Non-Pharmacological Treatments for Insomnia in Chronic Traumatic Brain Injury

Who this might be right for
InsomniaTraumatic Brain Injury
VA Office of Research and Development 110
Testing effectiveness (Phase 2)UnknownNCT02267915
What this trial is testing

Phase II of Efficacy and Toxicity of Maintenance Sub. Rituximab After Induction in Relapsed MCL and Non-eligible HSCT

Who this might be right for
Mantle-cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 36
Early research (Phase 1)UnknownNCT05088889
What this trial is testing

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Sheba Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06937866
What this trial is testing

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

Who this might be right for
Germ Cell Tumor
Indiana University 38
Large-scale testing (Phase 3)Active Not RecruitingNCT01874353
What this trial is testing

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Who this might be right for
Platinum SensitiveBRCA MutatedRelapsed Ovarian Cancer+1 more
AstraZeneca 327
Testing effectiveness (Phase 2)Ended earlyNCT00393796
What this trial is testing

Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma

Who this might be right for
Bladder Cancer
University of Michigan Rogel Cancer Center 54
Large-scale testing (Phase 3)UnknownNCT01224405
What this trial is testing

Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy

Who this might be right for
Advanced Prostate Cancer
University of Turin, Italy 600
Testing effectiveness (Phase 2)Study completedNCT00144131
What this trial is testing

Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy

Who this might be right for
AnemiaCancer
Amgen 750
Next Page